Background: Symptom control in patients with moderate-to-severe persistent allergic rhinitis (PAR) who remain inadequately controlled on intranasal corticosteroid monotherapy remains challenging, ...
A recent study found that people who took an allergy medicine were much less likely to get sick from COVID-19 and the common cold, the latest research to show promising results for nasal sprays in ...
While you're here: On Nov. 4, Californians will decide whether the state should gerrymander its congressional districts. Sign up for key updates on the special election. Along the highways of ...
Share on Pinterest A new trial shows that a common nasal spray may help lower the risk of contracting COVID-19 and other respiratory illnesses. Professional Studio Images/Getty Images Researchers say ...
A familiar allergy spray may do more than ease sneezing, researchers find azelastine could help block COVID-19 and other respiratory viruses, pointing to an accessible new line of defense. Study: ...
Naloxone, a nasal spray that is able to quickly reverse the effects of opioid overdoses while waiting for emergency services, will be offered to licensed venues as part of their first aid kits. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results